Michael Milligan
Fortuna: 38 913 $ al 31/05/2026
Fortuna: 38 913 $ al 31/05/2026
Michael Lee Milligan is currently Chief Financial Officer & Executive Vice President at New Haven Pharmaceuticals, Inc. and Chief Financial & Accounting Officer at Neumora Therapeutics, Inc. Former positions include Vice President Finance & Controller at Y-mAbs Therapeutics, Inc., Vice President-Finance & Controller at Acorda Therapeutics, Inc., and Chief Accounting Officer & Vice President at Shionogi, Inc. Education includes an MBA from Georgia State University and an undergraduate degree from the University of Miami.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/02/2026 | 21.034 ( 0,01 % ) | 38 913 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Director Financiero/CFO | 14/02/2025 |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Director Financiero/CFO | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Comptroller/Controller/Auditor | - |
| YMAS THER | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Georgia State University
Georgia State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.